Estrogen Receptor/ERR Inhibitors

Estrogen receptor

ERα

ERβ

ERRα

ERRβ

ERRγ

Estrogen Receptor/ERR Ligands, Degraders, Inhibitors, Agonists, Antagonists, Activators, Modulators & Chemicals

Product Name	Estrogen receptor	ERα	ERβ	ERRα	ERRβ	ERRγ	Purity
Tamoxifen	Estrogen receptor						99.96%
4-Hydroxytamoxifen	Estrogen receptor, IC₅₀: 3.3 nM						99.96%
Kaempferol		ERα					99.92%
Tamoxifen Citrate	Estrogen receptor						99.88%
(E/Z)-4-Hydroxytamoxifen	Estrogen receptor						99.62%
Propyl pyrazole triol		ERα					99.11%
DPN			ERβ, EC₅₀: 0.85 nM				99.66%
Raloxifene	Estrogen receptor						99.62%
Tamoxifen (Standard)	Estrogen receptor
SLU-PP-332				ERRα, EC₅₀: 98 nM	ERRβ, EC₅₀: 230 nM	ERRγ, EC₅₀: 430 nM	99.82%
Saikosaponin D			ERβ				99.78%
(Z)-Ligustilide		ERα					99.11%
XCT790				ERRα, IC₅₀: 0.37 μM			99.67%
GSK5182						ERRγ, IC₅₀: 79 nM	99.10%
DY131					ERRβ	ERRγ	99.72%
Giredestrant	ER						99.52%
MPP dihydrochloride		ERα	ERβ				99.54%
Smurf1-IN-A01		ERα					99.81%
Endoxifen		ERα					99.42%
ERRα antagonist-1				ERRα			99.71%
Palazestrant	17b-estradiol (E2), IC₅₀: 6.4 nM						99.90%
DS45500853				ERRα			99.18%
MPP hydrochloride		ERα	ERβ				99.28%
Zearalanone	Estrogen receptor						99.96%
Prinaberel		hERα, IC₅₀: 1200 nM mouse ERα, IC₅₀: 750 nM rat ERα, IC₅₀: 620 nM	hERβ, IC₅₀: 5.4 nM rat ERβ, IC₅₀: 3.1 nM mouse ERβ, IC₅₀: 3.7 nM				98.05%
Amcenestrant		ERα, EC₅₀: 0.2 nM					99.79%
GNE-149		ERα, IC₅₀: 0.053 nM					99.18%
(E)-4-Hydroxytamoxifen	Estrogen receptor						98.27%
Erteberel			ERβ, Ki: 1.54 nM ERβ, EC₅₀: 3.61 nM				99.49%
Kaempferol (Standard)		ERα
ERRγ agonist-1						ERRγ	98.02%
DS20362725				ERRα			99.34%
WAY-200070		ERα, IC₅₀: 155 nM	ERβ, IC₅₀: 2.3 nM				99.57%
FLTX1		ERα, IC₅₀: 87.5 nM					99.75%
PROTAC ERRα ligand 1				ERRα, IC₅₀: 0.04 μM		ERRγ, IC₅₀: 2.8 μM	99.47%
Hexestrol		ERα, Ki: 0.06 nM	ERβ, Ki: 0.06 nM				99.89%
(-)-(E)-Guggulsterone		ERα					99.27%
PROTAC ERα Degrader-2		ERα					98.92%
H3B-5942		ERα^Y537S, Ki: 0.41 nM ERα^WT, Ki: 1 nM					99.73%
Acolbifene		ERα, IC₅₀: 2 nM (E2-induced transcriptional activity)	ERβ, IC₅₀: 0.4 nM (E2-induced transcriptional activity)				99.52%
PROTAC ERα Degrader-4		ERα, Ki: 5.08 μM	ERβ, Ki: 26.20 μM				99.06%
PROTAC ERRα Degrader-3				ERRα			98.82%
PROTAC ER Degrader-4	ER						98.78%
Estrogen receptor β antagonist 2		ERα, IC₅₀: 109.10 μM	ERβ, IC₅₀: 0.63 μM				98.39%
Y134		ERα, Ki: 0.09 nM	ERβ, Ki: 11.31 nM				99.67%
OP-1074		ERα	ERβ				99.77%
Tamoxifen-d₅	Estrogen receptor						99.99%
PROTAC ERRα Degrader-1				ERRα			98.22%
Ferutinin		ERα, IC₅₀: 33.1 nM	ERβ, IC₅₀: 180.5 nM				99.23%
PHTPP-1304			ERβ, DC₅₀: 2 nM				99.96%
PROTAC ERα Degrader-6		ERα, DC₅₀: 0.12 μM
Acolbifene hydrochloride		ERα, IC₅₀: 2 nM (E2-induced transcriptional activity)	ERβ, IC₅₀: 0.4 nM (E2-induced transcriptional activity)				99.00%
Estrogen receptor-agonist-1		ERα					98.69%
ERα degrader-2		ERα, IC₅₀: 4.6 nM					99.71%
2-Hydroxyestrone	Estrogen receptor						98.57%
AC-186		ERα, EC₅₀: 5000 nM	ERβ, EC₅₀: 6 nM				99.61%
GTX-758		ERα					99.59%
ERRα antagonist-2				ERRα, IC₅₀: 0.80 μM			99.07%
ERα antagonist 1		ERα
(R,R)-THC		ERα, Ki: 9.0 nM	ERβ, Ki: 3.6 nM				99.0%
(±)-8-Prenylnaringenin		ERα, IC₅₀: 57 nM	ERβ, IC₅₀: 68 nM				99.97%
SR19881					ERRβ, EC₅₀: 0.63 μM	ERRγ, EC₅₀: 0.39 μM
LY117018	Estrogen receptor						99.47%
2-Ethylhexyl diphenyl phosphate						ERRγ, IC₅₀: 1.3 μM
X15695		ERα
Giredestrant tartrate	Estrogen receptor
(1S,3R)-GNE-502		ERα, EC₅₀: 13 nM
(+)-Medicarpin			ERβ
KAT6-IN-4		ERα
ERα degrader 5		ERα, EC₅₀: 1.1 nM ERα, IC₅₀: 0.9 nM	ERβ, IC₅₀: 2.3 nM
ERα degrader 9		ERα
ERα degrader 11		ERα
7β-Hydroxy-epi-androsterone			ERβ
Tamoxifen-PEG-Clozapine		ERα
PROTAC ERα Degrader-12		ERα
CHF 4227 free base		hERα, Ki: 0.017 nM	hERβ, Ki: 0.099 nM
LX-039	Estrogen receptor, EC₅₀: 2.29 nM
Estrogen receptor antagonist 8	Estrogen receptor
PROTAC ERα Degrader-9		ERα, Ki: 0.25 μM	ERβ, Ki: >79 μM
ERRγ inverse agonist 2						ERRγ, Kd: 6.5 μM
Anticancer agent 276		ERα
AZD9496-O-C3-O-C3-O-C-acid		ERα
4',2-Dihydroxy-4,6-dimethoxydihydrochalcone	Estrogen receptor
PVTX-321		ERα
Estrogen receptor modulator 6		ERα, Ki: 8.4 nM	ERβ, Ki: 0.44 nM
ERα degrader 10		ERα, IC₅₀: 24 nM
Estrogen receptor-IN-1		ERα, IC₅₀: 13 μM	ERβ, IC₅₀: 5 μM				99.87%
ER degrader 6		ERα
rel-Erteberel			ERβ, IC₅₀: 1.54 nM ERβ, EC₅₀: 3.61 nM
PSDalpha		ERα
CMP8		MGERα, IC₅₀: 29 nM MGRERα, IC₅₀: 41 nM hERα, IC₅₀: 1100 nM	hERβ, IC₅₀: 2200 nM
PROTAC ERα Degrader-7		ERα, DC₅₀: 0.000006 μM
PROTAC ERα Degrader-11		ERα	ERβ
BY13		ERα
SNG-8023		ERα
WAY-166818			ERβ
(R)-DPN		ERα, EC₅₀: 2.9 nM	ERβ, EC₅₀: 0.8 nM
FERb 033		ERα, EC₅₀: 19 nM	ERβ, EC₅₀: 4.8 nM ERβ, Ki: 7.1 nM
ERβ agonist-1			ERβ, EC₅₀: 46.8 nM
PROTAC ER Degrader-11	ER
LSD1/ER-IN-1		ERα	ERβ
4,4'-(Cyclohexylidenemethylene)diphenol		ERα	ERβ
Bisphenol C		ERα					≥98.0%
ERα/ERβ antagonist-1		ERα	ERβ
Isopaucifloral F			ERβ, EC₅₀: 46.96 μM
ERRγ inverse agonist 1		ERα, IC₅₀: 1.240 μM			ERRβ, IC₅₀: 1.330 μM	ERRγ, IC₅₀: 0.040 μM

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4